Addiction and the itch‐scratch cycle. What do they have in common?

Itch is a multidimensional experience involving various brain regions associated with sensory perception and emotion, as well as an urge to scratch employing the motor system. Scratch temporarily relieves itch sensation in healthy subjects. However, in patients with chronic itch, rather than inhibit...

Full description

Saved in:
Bibliographic Details
Published inExperimental dermatology Vol. 28; no. 12; pp. 1448 - 1454
Main Author Ishiuji, Yozo
Format Journal Article
LanguageEnglish
Published Denmark Wiley Subscription Services, Inc 01.12.2019
Subjects
Online AccessGet full text
ISSN0906-6705
1600-0625
1600-0625
DOI10.1111/exd.14029

Cover

Abstract Itch is a multidimensional experience involving various brain regions associated with sensory perception and emotion, as well as an urge to scratch employing the motor system. Scratch temporarily relieves itch sensation in healthy subjects. However, in patients with chronic itch, rather than inhibit, scratch may aggravate itch. Patients with chronic itch, such as those with atopic dermatitis, experience severe itch and a strong desire to scratch. This urge to scratch is the driving force underlying the formation of the itch‐scratch‐cycle, an addictive and vicious cycle in chronic itch patients. This vicious itch‐scratch behaviour and various types of addiction (henceforth, including recreational drug use) were shown to share common sensory mechanisms. Abnormalities have been observed in central neural circuits, including the reward, motivation/drive, control and learning/memory circuits, as well as other brain systems. Reward systems, including the ventral tegmental area (VTA), nucleus accumbens (NAc) and striatum, are important for brain processing of both addiction and itch. In addition to reward, addicted individuals can experience severe disruptions in motor control, cognitive awareness, executive function, learning/memory and even emotional functions. Findings showing that addiction and itch share a common neurobiological foundation could have important mechanistic and therapeutic implications. Here we propose that similar neuroadaptations exist in addiction and chronic itch patients.
AbstractList Itch is a multidimensional experience involving various brain regions associated with sensory perception and emotion, as well as an urge to scratch employing the motor system. Scratch temporarily relieves itch sensation in healthy subjects. However, in patients with chronic itch, rather than inhibit, scratch may aggravate itch. Patients with chronic itch, such as those with atopic dermatitis, experience severe itch and a strong desire to scratch. This urge to scratch is the driving force underlying the formation of the itch-scratch-cycle, an addictive and vicious cycle in chronic itch patients. This vicious itch-scratch behaviour and various types of addiction (henceforth, including recreational drug use) were shown to share common sensory mechanisms. Abnormalities have been observed in central neural circuits, including the reward, motivation/drive, control and learning/memory circuits, as well as other brain systems. Reward systems, including the ventral tegmental area (VTA), nucleus accumbens (NAc) and striatum, are important for brain processing of both addiction and itch. In addition to reward, addicted individuals can experience severe disruptions in motor control, cognitive awareness, executive function, learning/memory and even emotional functions. Findings showing that addiction and itch share a common neurobiological foundation could have important mechanistic and therapeutic implications. Here we propose that similar neuroadaptations exist in addiction and chronic itch patients.
Itch is a multidimensional experience involving various brain regions associated with sensory perception and emotion, as well as an urge to scratch employing the motor system. Scratch temporarily relieves itch sensation in healthy subjects. However, in patients with chronic itch, rather than inhibit, scratch may aggravate itch. Patients with chronic itch, such as those with atopic dermatitis, experience severe itch and a strong desire to scratch. This urge to scratch is the driving force underlying the formation of the itch-scratch-cycle, an addictive and vicious cycle in chronic itch patients. This vicious itch-scratch behaviour and various types of addiction (henceforth, including recreational drug use) were shown to share common sensory mechanisms. Abnormalities have been observed in central neural circuits, including the reward, motivation/drive, control and learning/memory circuits, as well as other brain systems. Reward systems, including the ventral tegmental area (VTA), nucleus accumbens (NAc) and striatum, are important for brain processing of both addiction and itch. In addition to reward, addicted individuals can experience severe disruptions in motor control, cognitive awareness, executive function, learning/memory and even emotional functions. Findings showing that addiction and itch share a common neurobiological foundation could have important mechanistic and therapeutic implications. Here we propose that similar neuroadaptations exist in addiction and chronic itch patients.Itch is a multidimensional experience involving various brain regions associated with sensory perception and emotion, as well as an urge to scratch employing the motor system. Scratch temporarily relieves itch sensation in healthy subjects. However, in patients with chronic itch, rather than inhibit, scratch may aggravate itch. Patients with chronic itch, such as those with atopic dermatitis, experience severe itch and a strong desire to scratch. This urge to scratch is the driving force underlying the formation of the itch-scratch-cycle, an addictive and vicious cycle in chronic itch patients. This vicious itch-scratch behaviour and various types of addiction (henceforth, including recreational drug use) were shown to share common sensory mechanisms. Abnormalities have been observed in central neural circuits, including the reward, motivation/drive, control and learning/memory circuits, as well as other brain systems. Reward systems, including the ventral tegmental area (VTA), nucleus accumbens (NAc) and striatum, are important for brain processing of both addiction and itch. In addition to reward, addicted individuals can experience severe disruptions in motor control, cognitive awareness, executive function, learning/memory and even emotional functions. Findings showing that addiction and itch share a common neurobiological foundation could have important mechanistic and therapeutic implications. Here we propose that similar neuroadaptations exist in addiction and chronic itch patients.
Author Ishiuji, Yozo
Author_xml – sequence: 1
  givenname: Yozo
  orcidid: 0000-0002-3941-4011
  surname: Ishiuji
  fullname: Ishiuji, Yozo
  email: yozoishiuji@gmail.com
  organization: The Jikei University School of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31482585$$D View this record in MEDLINE/PubMed
BookMark eNp1kctOwzAQRS1URB-w4AdQJDawSPEribNCVVseUiU2INhZru0oqZK42AmQHZ_AN_IlJLTdVDCbmZHOvRrNHYJeaUoNwCmCY9TWlf5QY0Qhjg_AAIUQ-jDEQQ8MYAxDP4xg0AdD51YQoohEwRHoE0QZDlgwALOJUpmsMlN6olRelWovq2T6_fnlpBXt5MlG5nrsPaei8pTpiMZLxVvLlZ40RWHK62NwmIjc6ZNtH4Gnm_nj9M5fPNzeTycLX5KAxL6SmrIYSsQSGNNui6JlzBCLsEhghDGmFFOhxVIkUuqQQUGkwjJkNIkVQWQELja-a2tea-0qXmRO6jwXpTa14xgzGoQ4Cjr0fA9dmdqW7XUcE8wwDSGJW-psS9XLQiu-tlkhbMN3_2mBqw0grXHO6oTLrBLduyorspwjyLsEeJsA_02gVVzuKXamf7Fb9_cs183_IJ-_zDaKH_L1ky4
CitedBy_id crossref_primary_10_3389_fmed_2023_1101935
crossref_primary_10_1111_exd_14403
crossref_primary_10_1016_j_nlm_2023_107760
crossref_primary_10_1016_j_jaad_2020_08_117
crossref_primary_10_1016_j_alit_2022_04_003
crossref_primary_10_3390_ijms23084140
crossref_primary_10_1186_s13041_024_01101_w
crossref_primary_10_1016_j_clindermatol_2025_03_005
crossref_primary_10_1016_j_actpsy_2023_104047
crossref_primary_10_1016_j_jfo_2022_09_009
crossref_primary_10_1155_2024_1494377
crossref_primary_10_3390_ijms21218406
crossref_primary_10_1126_scitranslmed_abn4819
crossref_primary_10_1016_j_anai_2020_11_008
crossref_primary_10_1186_s13020_022_00706_4
crossref_primary_10_1186_s40659_022_00396_0
crossref_primary_10_1016_j_bbrc_2020_11_030
crossref_primary_10_4103_ejdv_ejdv_18_22
crossref_primary_10_1016_j_brainres_2025_149492
crossref_primary_10_1111_exd_14058
crossref_primary_10_3390_jcm12041529
crossref_primary_10_1111_exd_14669
crossref_primary_10_2340_actadv_v103_9403
crossref_primary_10_2340_actadv_v104_35427
crossref_primary_10_3389_fmed_2021_627593
Cites_doi 10.1016/j.cell.2017.08.006
10.1016/j.neuron.2015.11.027
10.3164/jcbn.12-51
10.1038/jid.2015.223
10.31887/DCNS.2017.19.3/gkoob
10.1038/s41586-018-0740-8
10.3389/fpsyt.2018.00095
10.1152/jn.00070.2006
10.1111/ijd.12864
10.3389/fphar.2014.00256
10.1523/JNEUROSCI.2966-07.2007
10.1007/BF00426913
10.1016/S0304-3959(01)00271-8
10.1038/nm.3912
10.1111/j.1529-8019.2008.00166.x
10.1038/nature14188
10.1016/j.nicl.2014.12.002
10.3389/fpsyt.2016.00160
10.1038/s41598-018-19962-2
10.1016/j.neuron.2015.05.044
10.1016/j.neuron.2014.02.046
10.1007/s12016-015-8488-5
10.1016/j.neuropharm.2013.06.030
10.1523/JNEUROSCI.1979-13.2013
10.1016/j.neuron.2014.10.003
10.1152/jn.00827.2013
10.1056/NEJMcp1208814
10.1002/cne.24572
10.1016/j.neubiorev.2018.01.009
10.1111/ejn.13547
10.1523/JNEUROSCI.1267-16.2016
10.1016/j.brainres.2019.03.031
10.1016/j.neulet.2017.08.046
10.1016/j.neuron.2018.08.044
10.1523/JNEUROSCI.1978-13.2015
10.1038/bjp.2008.101
10.1016/j.drugalcdep.2013.02.025
10.1016/j.neures.2016.01.004
10.1038/nn1339
10.1248/bpb.b13-00319
10.1016/j.neuron.2019.03.030
10.2340/00015555-0890
10.1002/ejp.750
10.1016/j.cell.2015.07.046
10.1038/sj.npp.1301438
10.1016/j.jaad.2007.01.007
10.1038/nn1579
10.1016/j.tics.2015.05.005
10.1111/exd.12070
10.1111/j.1365-2133.2012.10826.x
10.1016/0006-8993(92)91327-B
10.1093/ntr/ntr163
10.1016/S0166-2236(03)00233-9
10.1152/jn.00374.2013
10.1523/JNEUROSCI.0143-04.2004
10.1038/npp.2013.261
10.1016/j.conb.2008.07.002
10.1038/jid.2012.52
10.1007/s11920-010-0135-5
10.1016/j.euroneuro.2018.01.007
10.1016/j.neuroimage.2004.08.023
10.1016/S0306-4522(00)00329-8
10.1111/exd.13305
10.1016/j.jaad.2016.02.1237
10.1111/all.12727
10.1038/s41593-018-0119-z
10.1111/all.13065
10.1016/j.jpain.2015.10.008
10.1523/JNEUROSCI.1483-18.2018
10.1177/0269881118764991
10.1016/0165-0173(93)90013-P
10.1016/j.jad.2014.04.055
10.2340/00015555-1353
10.1111/j.1365-2133.2009.09308.x
10.1016/j.jid.2015.12.037
ContentType Journal Article
Copyright 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Copyright_xml – notice: 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
– notice: 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
DBID AAYXX
CITATION
NPM
7T5
H94
K9.
NAPCQ
7X8
DOI 10.1111/exd.14029
DatabaseName CrossRef
PubMed
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList PubMed
CrossRef
AIDS and Cancer Research Abstracts

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1600-0625
EndPage 1454
ExternalDocumentID 31482585
10_1111_exd_14029
EXD14029
Genre article
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OB
1OC
29G
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
CYRXZ
D-6
D-7
D-E
D-F
DC6
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EAD
EAP
EBC
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FUBAC
FZ0
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YFH
YUY
ZZTAW
~IA
~WT
AAYXX
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
NPM
7T5
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
H94
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c3539-dce4890c18f094dce477b981872af072224424aeabafcce680a3cd2c684f9d313
IEDL.DBID DR2
ISSN 0906-6705
1600-0625
IngestDate Fri Jul 11 09:02:29 EDT 2025
Fri Jul 25 09:55:27 EDT 2025
Wed Feb 19 02:32:12 EST 2025
Tue Jul 01 01:14:49 EDT 2025
Thu Apr 24 22:57:22 EDT 2025
Wed Jan 22 16:40:30 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords reward
itch
vicious cycle
dopamine
addiction
Language English
License 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3539-dce4890c18f094dce477b981872af072224424aeabafcce680a3cd2c684f9d313
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-3941-4011
PMID 31482585
PQID 2328246039
PQPubID 2045157
PageCount 7
ParticipantIDs proquest_miscellaneous_2284562751
proquest_journals_2328246039
pubmed_primary_31482585
crossref_citationtrail_10_1111_exd_14029
crossref_primary_10_1111_exd_14029
wiley_primary_10_1111_exd_14029_EXD14029
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2019
2019-12-00
2019-Dec
20191201
PublicationDateYYYYMMDD 2019-12-01
PublicationDate_xml – month: 12
  year: 2019
  text: December 2019
PublicationDecade 2010
PublicationPlace Denmark
PublicationPlace_xml – name: Denmark
– name: Chichester
PublicationTitle Experimental dermatology
PublicationTitleAlternate Exp Dermatol
PublicationYear 2019
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2015; 35
2010; 12
2001; 92
2012; 166
2013; 22
2015; 70
2016; 108
2018; 564
2004; 7
2004; 23
2004; 24
2017; 45
2016; 75
2011; 13
2019; 527
2008; 33
2016; 71
2013; 17368
2013; 6
2016; 36
2018; 9
2018; 8
2014; 5
2012; 132
2013; 55
1992; 593
2015; 135
2019; 22
2018; 1
2015; 87
2013; 52
2009; 161
2008; 21
1979; 63
2014; 166
2008; 154
2018; 32
2018; 38
2016; 89
2007; 27
2015; 162
2017; 658
2018; 28
2015; 19
2017; 26
2008; 18
2017; 66
2017; 171
2016; 51
2007; 97
2014; 111
2016; 17
2014; 84
2018; 21
2015; 7
2014; 82
2007; 56
2014; 112
2016; 55
2012; 92
2016; 7
2018; 2018
2019; 1715
2013; 36
1993; 18
2013; 33
2005; 8
2015; 21
2016; 20
2003; 26
2018
2015; 517
2017; 19
2014
2013; 132
2000; 100
2016; 136
2014; 39
2018; 99
2010; 90
2014; 76
e_1_2_9_75_1
e_1_2_9_31_1
e_1_2_9_52_1
e_1_2_9_50_1
e_1_2_9_73_1
e_1_2_9_79_1
e_1_2_9_10_1
e_1_2_9_35_1
e_1_2_9_56_1
e_1_2_9_77_1
e_1_2_9_12_1
e_1_2_9_33_1
e_1_2_9_54_1
e_1_2_9_71_1
Jones O. (e_1_2_9_80_1) 2018
e_1_2_9_14_1
e_1_2_9_39_1
e_1_2_9_16_1
e_1_2_9_37_1
e_1_2_9_58_1
e_1_2_9_18_1
e_1_2_9_41_1
e_1_2_9_64_1
e_1_2_9_62_1
e_1_2_9_22_1
e_1_2_9_45_1
e_1_2_9_68_1
e_1_2_9_83_1
e_1_2_9_24_1
Ko M‐C (e_1_2_9_29_1) 2014
e_1_2_9_43_1
e_1_2_9_66_1
e_1_2_9_8_1
e_1_2_9_6_1
e_1_2_9_81_1
e_1_2_9_4_1
Bigliardi P. L. (e_1_2_9_28_1) 2014
George O. (e_1_2_9_20_1) 2017; 19
Luigjes J. (e_1_2_9_82_1) 2013; 55
e_1_2_9_26_1
e_1_2_9_49_1
e_1_2_9_47_1
e_1_2_9_30_1
e_1_2_9_74_1
e_1_2_9_51_1
e_1_2_9_72_1
e_1_2_9_11_1
e_1_2_9_34_1
e_1_2_9_57_1
e_1_2_9_78_1
e_1_2_9_13_1
e_1_2_9_32_1
e_1_2_9_55_1
e_1_2_9_76_1
e_1_2_9_70_1
e_1_2_9_15_1
e_1_2_9_38_1
e_1_2_9_17_1
e_1_2_9_36_1
e_1_2_9_59_1
e_1_2_9_19_1
e_1_2_9_42_1
e_1_2_9_63_1
e_1_2_9_40_1
e_1_2_9_61_1
e_1_2_9_21_1
e_1_2_9_46_1
e_1_2_9_67_1
e_1_2_9_23_1
e_1_2_9_44_1
e_1_2_9_65_1
e_1_2_9_7_1
e_1_2_9_5_1
Papoiu A. D. P. (e_1_2_9_2_1) 2013; 6
e_1_2_9_3_1
Ishiuji Y. (e_1_2_9_53_1) 2017; 66
Browne C. J. (e_1_2_9_60_1) 2018; 1
e_1_2_9_9_1
e_1_2_9_25_1
e_1_2_9_27_1
e_1_2_9_48_1
e_1_2_9_69_1
References_xml – volume: 6
  start-page: 12
  issue: 8
  year: 2013
  publication-title: PLoS One
– volume: 21
  start-page: 22
  year: 2008
  publication-title: Dermatol Ther
– start-page: 18
  year: 2014
– volume: 162
  start-page: 712
  year: 2015
  publication-title: Cell
– volume: 90
  start-page: 354
  year: 2010
  publication-title: Acta Derm Venereol
– volume: 12
  start-page: 448
  year: 2010
  publication-title: Curr Psychiatry Rep
– volume: 8
  start-page: 1481
  year: 2005
  publication-title: Nat Neurosci
– volume: 135
  start-page: 2814
  year: 2015
  publication-title: J Invest Dermatol
– volume: 132
  start-page: 395
  year: 2013
  publication-title: Drug Alcohol Depend
– volume: 75
  start-page: 619
  year: 2016
  publication-title: J Am Acad Dermatol
– volume: 89
  start-page: 11
  year: 2016
  publication-title: Neuron
– volume: 8
  start-page: 1725
  year: 2018
  publication-title: Sci Rep
– volume: 112
  start-page: 1729
  year: 2014
  publication-title: J Neurophysiol
– volume: 593
  start-page: 314
  year: 1992
  publication-title: Brain Res
– volume: 55
  start-page: 841
  year: 2013
  publication-title: Tijdschr Psychiatr
– volume: 27
  start-page: 14035
  year: 2007
  publication-title: J Neurosci
– volume: 87
  start-page: 124
  year: 2015
  publication-title: Neuron
– volume: 166
  start-page: 981
  year: 2012
  publication-title: Br J Dermatol
– volume: 70
  start-page: 1485
  year: 2015
  publication-title: Allergy
– volume: 136
  start-page: 879
  year: 2016
  publication-title: J Invest Dermatol
– volume: 92
  start-page: 555
  year: 2012
  publication-title: Acta Derm Venereol
– volume: 55
  start-page: 434
  year: 2016
  publication-title: Int J Dermatol
– volume: 97
  start-page: 415
  year: 2007
  publication-title: J Neurophysiol
– volume: 21
  start-page: 707
  year: 2018
  publication-title: Nat Neurosci
– volume: 92
  start-page: 295
  year: 2001
  publication-title: Pain
– volume: 7
  start-page: 160
  year: 2016
  publication-title: Front Psychiatry
– volume: 35
  start-page: 4296
  year: 2015
  publication-title: J Neurosci
– volume: 527
  start-page: 916
  year: 2019
  publication-title: J Comp Neurol
– volume: 32
  start-page: 1010
  year: 2018
  publication-title: J Psychopharmacol
– volume: 82
  start-page: 573
  year: 2014
  publication-title: Neuron
– volume: 56
  start-page: 979
  year: 2007
  publication-title: J Am Acad Dermatol
– volume: 38
  start-page: 9856
  year: 2018
  publication-title: J Neurosci
– volume: 39
  start-page: 254
  year: 2014
  publication-title: Neuropsychopharmacology
– volume: 171
  start-page: 217
  year: 2017
  publication-title: Cell
– volume: 5
  start-page: 256
  year: 2014
  publication-title: Front Pharmacol
– volume: 22
  start-page: 239
  year: 2013
  publication-title: Exp Dermatol
– volume: 111
  start-page: 488
  issue: 3
  year: 2014
  publication-title: J Neurophysiol
– volume: 36
  start-page: 1241
  year: 2013
  publication-title: Biol Pharm Bull
– volume: 99
  start-page: 1274
  year: 2018
  publication-title: Neuron
– volume: 84
  start-page: 821
  year: 2014
  publication-title: Neuron
– volume: 76
  start-page: 460
  year: 2014
  publication-title: Neuropharmacology
– volume: 45
  start-page: 1313
  year: 2017
  publication-title: Eur J Neurosci
– volume: 17
  start-page: 181
  year: 2016
  publication-title: J Pain
– volume: 108
  start-page: 1
  year: 2016
  publication-title: Neurosci Res
– volume: 9
  start-page: 95
  year: 2018
  publication-title: Front Psychiatry
– volume: 33
  start-page: 643
  year: 2008
  publication-title: Neuropsychopharmacology
– volume: 658
  start-page: 91
  year: 2017
  publication-title: Neurosci Lett
– volume: 22
  start-page: 858
  issue: 102
  year: 2019
  publication-title: Neuron
– volume: 517
  start-page: 284
  year: 2015
  publication-title: Nature
– volume: 20
  start-page: 8
  year: 2016
  publication-title: Eur J Pain
– volume: 23
  start-page: 1486
  year: 2004
  publication-title: NeuroImage
– volume: 18
  start-page: 203
  year: 2008
  publication-title: Curr Opin Neurobiol
– start-page: 25
  year: 2014
– volume: 1
  year: 2018
  publication-title: Neuropsychopharmacology
– volume: 161
  start-page: 1072
  year: 2009
  publication-title: Br J Dermatol
– volume: 17368
  start-page: 1625
  year: 2013
  publication-title: N Engl J Med
– volume: 564
  start-page: 258
  year: 2018
  publication-title: Nature
– volume: 19
  start-page: 217
  year: 2017
  publication-title: Dialogues Clin Neurosci
– volume: 26
  start-page: 507
  year: 2003
  publication-title: Trends Neurosci
– volume: 154
  start-page: 397
  year: 2008
  publication-title: Br J Pharmacol
– volume: 33
  start-page: 19384
  year: 2013
  publication-title: J Neurosci
– volume: 71
  start-page: 1666
  year: 2016
  publication-title: Allergy
– volume: 24
  start-page: 5000
  year: 2004
  publication-title: J Neurosci
– volume: 26
  start-page: 845
  year: 2017
  publication-title: Exp Dermatol
– volume: 21
  start-page: 927
  year: 2015
  publication-title: Nat Med
– volume: 18
  start-page: 247
  year: 1993
  publication-title: Brain Res Rev
– volume: 7
  start-page: 1259
  year: 2004
  publication-title: Nat Neurosci
– year: 2018
  publication-title: Exp Dermatol
– volume: 132
  start-page: 1886
  year: 2012
  publication-title: J Invest Dermatol
– volume: 36
  start-page: 10729
  year: 2016
  publication-title: J Neurosci
– volume: 166
  start-page: 93
  year: 2014
  publication-title: J Affect Disord
– volume: 2018
  start-page: 17
  issue: 87
  year: 2018
  publication-title: Neurosci Biobehav Rev
– volume: 66
  start-page: 777
  issue: 6
  year: 2017
  end-page: 782
  publication-title: Arerugi.
– volume: 1715
  start-page: 224
  year: 2019
  publication-title: Brain Res
– volume: 52
  start-page: 58
  year: 2013
  publication-title: J Clin Biochem Nutr
– volume: 51
  start-page: 263
  year: 2016
  publication-title: Clin Rev Allergy Immunol
– volume: 100
  start-page: 861
  year: 2000
  publication-title: Neuroscience
– volume: 28
  start-page: 341
  year: 2018
  publication-title: Eur Neuropsychopharmacol
– volume: 7
  start-page: 213
  year: 2015
  publication-title: NeuroImage Clin
– volume: 63
  start-page: 7
  year: 1979
  publication-title: Psychopharmacology
– volume: 19
  start-page: 414
  year: 2015
  publication-title: Trends Cogn Sci
– volume: 13
  start-page: 1140
  year: 2011
  publication-title: Nicotine Tob Res
– ident: e_1_2_9_11_1
  doi: 10.1016/j.cell.2017.08.006
– ident: e_1_2_9_7_1
  doi: 10.1016/j.neuron.2015.11.027
– ident: e_1_2_9_83_1
  doi: 10.3164/jcbn.12-51
– ident: e_1_2_9_3_1
  doi: 10.1038/jid.2015.223
– volume: 19
  start-page: 217
  year: 2017
  ident: e_1_2_9_20_1
  publication-title: Dialogues Clin Neurosci
  doi: 10.31887/DCNS.2017.19.3/gkoob
– ident: e_1_2_9_55_1
  doi: 10.1038/s41586-018-0740-8
– volume: 6
  start-page: 12
  issue: 8
  year: 2013
  ident: e_1_2_9_2_1
  publication-title: PLoS One
– ident: e_1_2_9_79_1
  doi: 10.3389/fpsyt.2018.00095
– ident: e_1_2_9_49_1
  doi: 10.1152/jn.00070.2006
– ident: e_1_2_9_56_1
  doi: 10.1111/ijd.12864
– ident: e_1_2_9_27_1
  doi: 10.3389/fphar.2014.00256
– ident: e_1_2_9_37_1
  doi: 10.1523/JNEUROSCI.2966-07.2007
– ident: e_1_2_9_61_1
  doi: 10.1007/BF00426913
– ident: e_1_2_9_38_1
  doi: 10.1016/S0304-3959(01)00271-8
– ident: e_1_2_9_14_1
  doi: 10.1038/nm.3912
– ident: e_1_2_9_47_1
  doi: 10.1111/j.1529-8019.2008.00166.x
– ident: e_1_2_9_57_1
  doi: 10.1038/nature14188
– ident: e_1_2_9_16_1
  doi: 10.1016/j.nicl.2014.12.002
– ident: e_1_2_9_31_1
  doi: 10.3389/fpsyt.2016.00160
– ident: e_1_2_9_34_1
  doi: 10.1038/s41598-018-19962-2
– volume: 1
  year: 2018
  ident: e_1_2_9_60_1
  publication-title: Neuropsychopharmacology
– ident: e_1_2_9_62_1
  doi: 10.1016/j.neuron.2015.05.044
– ident: e_1_2_9_69_1
  doi: 10.1016/j.neuron.2014.02.046
– ident: e_1_2_9_13_1
  doi: 10.1007/s12016-015-8488-5
– ident: e_1_2_9_26_1
  doi: 10.1016/j.neuropharm.2013.06.030
– ident: e_1_2_9_41_1
  doi: 10.1523/JNEUROSCI.1979-13.2013
– ident: e_1_2_9_64_1
  doi: 10.1016/j.neuron.2014.10.003
– ident: e_1_2_9_17_1
  doi: 10.1152/jn.00827.2013
– ident: e_1_2_9_10_1
  doi: 10.1056/NEJMcp1208814
– ident: e_1_2_9_30_1
  doi: 10.1002/cne.24572
– ident: e_1_2_9_4_1
  doi: 10.1016/j.neubiorev.2018.01.009
– ident: e_1_2_9_54_1
  doi: 10.1111/ejn.13547
– ident: e_1_2_9_58_1
  doi: 10.1523/JNEUROSCI.1267-16.2016
– volume: 55
  start-page: 841
  year: 2013
  ident: e_1_2_9_82_1
  publication-title: Tijdschr Psychiatr
– ident: e_1_2_9_63_1
  doi: 10.1016/j.brainres.2019.03.031
– start-page: 25
  volume-title: Roles of central opioid receptor subtypes in regulating itch sensation
  year: 2014
  ident: e_1_2_9_29_1
– ident: e_1_2_9_39_1
  doi: 10.1016/j.neulet.2017.08.046
– ident: e_1_2_9_67_1
  doi: 10.1016/j.neuron.2018.08.044
– ident: e_1_2_9_42_1
  doi: 10.1523/JNEUROSCI.1978-13.2015
– ident: e_1_2_9_65_1
  doi: 10.1038/bjp.2008.101
– ident: e_1_2_9_43_1
  doi: 10.1016/j.drugalcdep.2013.02.025
– ident: e_1_2_9_22_1
  doi: 10.1016/j.neures.2016.01.004
– ident: e_1_2_9_50_1
  doi: 10.1038/nn1339
– ident: e_1_2_9_12_1
  doi: 10.1248/bpb.b13-00319
– ident: e_1_2_9_25_1
  doi: 10.1016/j.neuron.2019.03.030
– ident: e_1_2_9_44_1
  doi: 10.2340/00015555-0890
– ident: e_1_2_9_52_1
  doi: 10.1002/ejp.750
– start-page: 18
  volume-title: Peripheral Opioids
  year: 2014
  ident: e_1_2_9_28_1
– ident: e_1_2_9_8_1
  doi: 10.1016/j.cell.2015.07.046
– volume: 66
  start-page: 777
  issue: 6
  year: 2017
  ident: e_1_2_9_53_1
  publication-title: Arerugi.
– ident: e_1_2_9_40_1
  doi: 10.1038/sj.npp.1301438
– ident: e_1_2_9_76_1
  doi: 10.1016/j.jaad.2007.01.007
– ident: e_1_2_9_33_1
  doi: 10.1038/nn1579
– ident: e_1_2_9_35_1
  doi: 10.1016/j.tics.2015.05.005
– ident: e_1_2_9_45_1
  doi: 10.1111/exd.12070
– ident: e_1_2_9_6_1
  doi: 10.1111/j.1365-2133.2012.10826.x
– ident: e_1_2_9_32_1
  doi: 10.1016/0006-8993(92)91327-B
– ident: e_1_2_9_73_1
  doi: 10.1093/ntr/ntr163
– ident: e_1_2_9_19_1
  doi: 10.1016/S0166-2236(03)00233-9
– ident: e_1_2_9_5_1
  doi: 10.1152/jn.00374.2013
– ident: e_1_2_9_46_1
  doi: 10.1523/JNEUROSCI.0143-04.2004
– year: 2018
  ident: e_1_2_9_80_1
  publication-title: Exp Dermatol
– ident: e_1_2_9_21_1
  doi: 10.1038/npp.2013.261
– ident: e_1_2_9_48_1
  doi: 10.1016/j.conb.2008.07.002
– ident: e_1_2_9_75_1
  doi: 10.1038/jid.2012.52
– ident: e_1_2_9_74_1
  doi: 10.1007/s11920-010-0135-5
– ident: e_1_2_9_72_1
  doi: 10.1016/j.euroneuro.2018.01.007
– ident: e_1_2_9_36_1
  doi: 10.1016/j.neuroimage.2004.08.023
– ident: e_1_2_9_66_1
  doi: 10.1016/S0306-4522(00)00329-8
– ident: e_1_2_9_9_1
  doi: 10.1111/exd.13305
– ident: e_1_2_9_81_1
  doi: 10.1016/j.jaad.2016.02.1237
– ident: e_1_2_9_51_1
  doi: 10.1111/all.12727
– ident: e_1_2_9_68_1
  doi: 10.1038/s41593-018-0119-z
– ident: e_1_2_9_77_1
  doi: 10.1111/all.13065
– ident: e_1_2_9_59_1
  doi: 10.1016/j.jpain.2015.10.008
– ident: e_1_2_9_24_1
  doi: 10.1523/JNEUROSCI.1483-18.2018
– ident: e_1_2_9_71_1
  doi: 10.1177/0269881118764991
– ident: e_1_2_9_23_1
  doi: 10.1016/0165-0173(93)90013-P
– ident: e_1_2_9_78_1
  doi: 10.1016/j.jad.2014.04.055
– ident: e_1_2_9_70_1
  doi: 10.2340/00015555-1353
– ident: e_1_2_9_18_1
  doi: 10.1111/j.1365-2133.2009.09308.x
– ident: e_1_2_9_15_1
  doi: 10.1016/j.jid.2015.12.037
SSID ssj0017375
Score 2.4063346
SecondaryResourceType review_article
Snippet Itch is a multidimensional experience involving various brain regions associated with sensory perception and emotion, as well as an urge to scratch employing...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1448
SubjectTerms addiction
Addictions
Atopic dermatitis
Circuits
Cognitive ability
dopamine
Drug addiction
Executive function
itch
Learning
Memory
Motivation
Motor task performance
Neostriatum
Neural networks
Nucleus accumbens
Reinforcement
reward
Ventral tegmentum
vicious cycle
Title Addiction and the itch‐scratch cycle. What do they have in common?
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fexd.14029
https://www.ncbi.nlm.nih.gov/pubmed/31482585
https://www.proquest.com/docview/2328246039
https://www.proquest.com/docview/2284562751
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8QwEA7iQbz4fqyuEsWDly5pk7YJHmRxVxZhPYjCHoSSV1GUruiuqCd_gr_RX-KkL1wfIN5aMiFpJjPzTZN8QWiPM-d5feMFLA09iHjc44wbL5ZSKBGJUGmXKPZPo94FOxmEgyl0UJ2FKfgh6h9uzjJyf-0MXKqHT0ZunwyYOQnc4T2fRo43v3NWU0f5Mc1JdomAjDmKSViyCrldPHXNyVj0DWBO4tU84BzPo8uqq8U-k5vWeKRa-uULi-M_v2UBzZVAFLeLmbOIpmy2hGb65VL7Muq0jbnODz1gmRkMOBFfg4bfX9_A0YD_vsL6GSq2sCP_xmboJJ7xlXwEuQxDB2B-H66gi-Pu-VHPK69c8DQNqfCMtowLon2eQt7n3uJYCQjqcSBTEgOYYCxg0kolU61txImk2gQ64iwVhvp0FU1nw8yuI6whl9KMkRQAA5NpxC1hWlHfKKs081kD7VeDn-iSj9xdi3GbVHkJjEqSj0oD7daidwUJx09CzUqDSWmHDwngRR6wiFAo3qmLwYLcsojM7HAMMhChQ0fW7DfQWqH5uhXqaFIho4LO5vr7vfmkO-jkDxt_F91Es4C_RLE7pommR_djuwUYZ6S288n8Aa5l9fY
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgEXXqVloYBBHHrJyokniS0hoYpttUC3B9RKe6kiv6JWRVnU7qK2J34Cv5Ffwjgv0dJKiFuijGXH45n5xo_PAG8lBs8buyjBMo0o4slIonRRrrUyKlOpsSFRnOxm4338NE2nS_CuOwvT8EP0E27BMmp_HQw8TEj_YeX-zJGd80TdgttIQCOkXqMvPXlUnIuaZpcrypmznKctr1DYx9MXvRyN_oKYlxFrHXK2H8BB19hmp8nxcDE3Q3txhcfxf__mIdxvsSjbbAbPI1jy1WO4M2lX21dgtOncUX3ugenKMYKK7IiU_OvHT_I15MIPmT2ngkMW-L-ZmwWJc3aov5NcxagFNMTfP4H97a29D-OovXUhsiIVKnLWo1TcxrKk1C-85blRFNfzRJc8JzyBmKD22ujSWp9JroV1ic0klsqJWKzCcjWr_FNgltIpi8hLwgyoy0x6jtaI2BlvLMY4gI2u9wvbUpKHmzG-Fl1qQr1S1L0ygDe96LeGh-M6ofVOhUVriqcFQUaZYMYFfX7dfyYjCisjuvKzBclQkE4DX3M8gLVG9X0tIjClUlJFja0VeHP1xdZ0VD88-3fRV3B3vDfZKXY-7n5-DvcIjqlms8w6LM9PFv4FQZ65eVmP7N8Yp_oV
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JT9wwFH5ikRAXoGXpwLS4FQcuGSWxk9jqoUIMIyiLEAJpDkiRtwhUlEHtDGI48RP4jf0lfc6mskmIWyI_y479lu_F9meADc6c5w2MF7Is8jDicY8zbrxESqFELCKlXaJ4eBTvnrGf_ag_Ad_rszAlP0Tzw81ZRuGvnYFfm-w_I7e3Bs3cD8UkTLMYkYRDRCcNd1SQ0IJl1xeYMseJH1W0Qm4bT1P1cTB6hjAfA9Yi4vTm4bzua7nR5FdnNFQdffeExvGdH7MAcxUSJVul6nyACZt_hJnDaq19EbpbxlwWpx6IzA1BoEgucYr_3j-gp0EHfkH0GCt2iGP_JmbgJMbkQt6gXE6wA6jgP5bgrLdzur3rVXcueJpGVHhGW8aFrwOeYeLn3pJECYzqSSgzP0E0wVjIpJVKZlrbmPuSahPqmLNMGBrQZZjKB7n9BERjMqUZ8zNEDExmMbc-04oGRlmlWcBasFkPfqorQnJ3L8ZVWicmOCppMSot-NaIXpcsHC8JtesZTCtD_JMiYOQhqgfF4q9NMZqQWxeRuR2MUAZDdOTYmoMWrJQz37RCHU8qplTY2WL-Xm8-3el3i4fVt4uuw8xxt5ce7B3tr8EsYjFR7pRpw9Tw98h-RrwzVF8Kvf4HMLv4xA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Addiction+and+the+itch-scratch+cycle.+What+do+they+have+in+common%3F&rft.jtitle=Experimental+dermatology&rft.au=Ishiuji%2C+Yozo&rft.date=2019-12-01&rft.eissn=1600-0625&rft.volume=28&rft.issue=12&rft.spage=1448&rft_id=info:doi/10.1111%2Fexd.14029&rft_id=info%3Apmid%2F31482585&rft.externalDocID=31482585
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0906-6705&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0906-6705&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0906-6705&client=summon